Clinical Trial Update: A Randomized Study of TH Versus THL in First Line Treatment of HER2-positive Metastatic Breast Cancer [Phase 3]

View source ↗

Summary

Phase 3 randomized study comparing TH versus THL as first-line therapy for HER2-positive metastatic breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• TH
• THL

Snippet

Sponsor: Cancer Trials Ireland | Conditions: Metastatic Breast Cancer | Phase 3 | Status: COMPLETED